RefleXion is developing biology-guided radiotherapy (BgRT)*, a new treatment modality that we envision may potentiate the effects of chemotherapy, immunotherapy, and targeted drugs to improve outcomes for cancer patients, including those with metastatic disease. BgRT is the first and only type of radiotherapy that utilizes each cancer’s unique biology to guide radiation delivery, even in tumors that are moving.
*The RefleXion® X1 is approved for SBRT/SRT/IMRT. BgRT is pending regulatory review and is not commercially available.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
No